Published case reports and cohort studies of moyamoya angiopathy have repeatedly described coexisting autoimmune histories. This suggests that systemic autoimmunity may represent an underrecognized clinical pattern rather than an isolated coincidence. Prior literature describing the autoimmune-moyamoya association includes case reports, case series, and retrospective reviews. This is supporting the possibility that autoimmune disorders may be part of a broader immune-associated phenotype rather than an isolated comorbidity. Proposed mechanisms include immune-mediated endothelial injury, inflammatory vascular remodeling, abnormal angiogenic signaling, and interactions between systemic inflammation and underlying MMD susceptibility pathways.
Our previously reported clinical case, involving a young woman with T1DM, elevated inflammatory markers, hyperglycemia and angiographic findings consistent with MMD, served as the rationale for examining this association in the literature.